CBAY - CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01 March, 16 2023 04:08 PM CymaBay Therapeutics Inc. 2023-03-16 16:08:47 ET CymaBay Therapeutics press release ( NASDAQ: CBAY ): Q4 GAAP EPS of -$0.30 misses by $0.01 . Held $135.5 million in cash, cash equivalents and investments as of December 31, 2022. For further details see: CymaBay Therapeutics GAAP EPS of -$0.30 misses by $0.01